Text 4847, 136 rader
Skriven 2007-06-20 23:30:58 av Whitehouse Press (1:3634/12.0)
Ärende: Press Release (0706206) for Wed, 2007 Jun 20
====================================================

===========================================================================
Executive Order: Expanding Approved Stem Cell Lines in Ethically
Responsible Ways
===========================================================================

For Immediate Release Office of the Press Secretary June 20, 2007

Executive Order: Expanding Approved Stem Cell Lines in Ethically
Responsible Ways

˙˙White House News

˙˙˙˙˙ President Bush Discusses Stem Cell Veto and Executive Order ˙˙˙˙˙
Message to the Senate of the United States ˙˙˙˙˙ Fact Sheet: Advancing Stem
Cell Research While Respecting Moral Boundaries

˙˙˙˙˙˙˙˙By the authority vested in me as President by the Constitution and
the laws of the UnitedStates of America, and to provide leadership with
respect to research on pluripotent stem cells derived by ethically
responsible techniques so that the potential of pluripotent stem cells can
be explored without violating human dignity or demeaning human life, it is
hereby ordered as follows:

˙˙˙˙Section1. Research on Alternative Sources of Pluripotent Stem Cells.
(a) The Secretary of Health and Human Services (Secretary) shall conduct
and support research on the isolation, derivation, production, and testing
of stem cells that are capable of producing all oralmost allof the cell
types of the developing body and may result in improved understanding of or
treatments for diseases and other adverse health conditions, butare derived
without creating a human embryo for research purposes or destroying,
discarding, orsubjecting to harm a human embryo or fetus.

˙˙˙˙˙˙˙˙(b) Within 90days of this order, the Secretary, after such
consultation with the Director of the National Institutes of Health
(Director), shall issue a plan, including such mechanisms as requests for
proposals, requests for applications, program announcements and other
appropriate means, to implement subsection(a) of this section, that:

˙˙˙˙˙˙˙˙(i) specifies and reflects adetermination of the extent to which
specific techniques may require additional basic or animal research to
ensure that any research involving human cells using these techniques is
clearly consistent with the standards established under this order and
applicable law;

˙˙˙˙˙˙˙˙(ii) prioritizes research with the greatest potential forclinical
benefit;

˙˙˙˙˙˙˙˙(iii) takes into account techniques outlined by the President's
Council on Bioethics, and any other appropriate techniques and research,
provided they clearly meet the standard set forth in subsection(a) of this
section;

˙˙˙˙˙˙˙˙(iv) renames the "Human Embryonic Stem Cell Registry" the"Human
Pluripotent Stem Cell Registry;" and

˙˙˙˙˙˙˙˙(v) adds to the registry new human pluripotent stem celllines that
clearly meet the standard set forth in subsection (a) of this section.

˙˙˙˙(c) Not later than December 31 of each year, the Secretary shall report
to the President on the activities carried out under this order during the
past fiscal year, including a description of the research carried out or
supported by the Department of Health and Human Services, including the
National Institutes of Health, and other developments in the science of
pluripotent stem cells not derived from human embryos.

˙˙˙˙Sec. 2. Policy. The activities undertaken and supported by and under
the direction of the Secretary shall be clearly consistent with the
following policies and principles:

˙˙˙˙(a) the purposes of this order are (i) to direct the Department of
Health and Human Services, including the National Institutes of Health, to
intensify peer reviewed research that may result in improved understanding
ofortreatments for diseases and other adverse health conditions, and (ii)
to promote the derivation of human pluriđpotent stem cell lines
fromavariety of alternative sources while clearly meeting thestandard set
forth insection 1(a) of this order;

˙˙˙˙(b) it is critical to establish moral and ethical boundaries to allow
the Nation to move forward vigorously withmedical research, while also
maintaining the highest ethical standards and respecting human life and
human dignity;

˙˙˙˙(c) the destruction of nascent life for research violates the principle
that no life should be used as a mere means for achieving the medical
benefit of another;

˙˙˙˙(d) human embryos and fetuses, as living members of thehuman species,
are not raw materials to be exploited orcommodities to be bought and sold;
and

˙˙˙˙(e) the Federal Government has a duty to exercise responsible
stewardship of taxpayer funds, both supporting important medical research
and respecting ethical and moral boundaries.

˙˙˙˙Sec. 3. Interpretation of this Order. (a) For purposes of this order,
the term "human embryo" shall mean anyorganism, not protected as a human
subject under 45 CFR 46 as of the dateof this order, that is derived by
fertilization, parthenođgenesis, cloning, or any other means from one or
more human gametes or human diploid cells.

˙˙˙˙(b) For purposes of this order, the term "subjecting to harm a human
embryo" shall mean subjecting such an embryo to risk of injury or death
greater than that allowed for research on fetuses in utero under 45CFR
46.204(b) and section498(b) ofthe Public Health Service Act (42U.S.C.
289g(b)) as of the date of this order.

˙˙˙˙(c) Nothing in this order shall be construed to affect anypolicy,
guideline, or regulation regarding embryonic stem cell research, human
cloning by somatic cell nuclear transfer, or any other research not
specifically authorized by this order, or toforbid the use of existing stem
cell lines deemed eligible forother federally funded research in accordance
with the presidential policy decision of August9, 2001, for research
specifically authorized by this order.

˙˙˙˙Sec. 4. General Provisions. (a) This order shall be implemented
consistent with applicable law and subject to the availability of
appropriations.

˙˙˙˙(b) This order is not intended to, and does not, create any right,
benefit, or privilege, substantive or procedural, enforceable atlaw or in
equity, by any party against the UnitedStates, itsdepartments, agencies, or
entities, its officers, employees, or agents, or any other person.

GEORGE W. BUSH

THE WHITE HOUSE,

˙˙˙˙June 20, 2007.

# # #
===========================================================================
Return to this article at:
http://www.whitehouse.gov/news/releases/2007/06/20070620-6.html

 * Origin: (1:3634/12)